Literature DB >> 25177056

Effectiveness of the U.S. national HIV testing day campaigns in promoting HIV testing: evidence from CDC-funded HIV testing sites, 2010.

Michelle Van Handel1, Mesfin S Mulatu1.   

Abstract

OBJECTIVES: We assessed if HIV testing and diagnoses increased during the week of National HIV Testing Day (NHTD) and if characteristics of people who were tested varied compared with control weeks.
METHODS: We analyzed HIV testing data from the 2010 National HIV Prevention Program Monitoring and Evaluation system to compare NHTD week (June 24-30, 2010) with two control weeks (January 7-13, 2010, and August 12-18, 2010) for the number of HIV testing events and new HIV-positive diagnoses, by demographics and other HIV-related variables. Characteristics associated with testing during NHTD week compared with control weeks were identified using Chi-square analyses.
RESULTS: In 2010, an average of 15,000 more testing events were conducted and 100 more new HIV-positive diagnoses were identified during NHTD week than during the control weeks (p<0.001). Compared with control weeks, people tested during NHTD week were significantly less likely to be aged 20-29 years and non-Hispanic white and significantly more likely to be (1) aged ≥ 50 years, (2) non-Hispanic black or African American, (3) men who have sex with men, (4) low-risk heterosexuals, (5) tested with a rapid HIV test, or (6) tested in a non-health-care setting.
CONCLUSION: In 2010, CDC-funded HIV testing events and new HIV-positive diagnoses increased during NHTD week compared with control weeks. HIV testing programs increased the use of rapid tests and returned a high percentage of test results. NHTD campaigns reached populations disproportionately affected by HIV and further expanded testing to people traditionally less likely to be tested. Incorporating strategies used during NHTD in programs conducted throughout the year may assist in increasing HIV testing and the number of HIV-positive diagnoses.

Entities:  

Mesh:

Year:  2014        PMID: 25177056      PMCID: PMC4116372          DOI: 10.1177/003335491412900508

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  14 in total

1.  Barriers to HIV-testing among Hispanics in the United States: analysis of the National Health Interview Survey, 2000.

Authors:  Catalina Lopez-Quintero; Ronny Shtarkshall; Yehuda D Neumark
Journal:  AIDS Patient Care STDS       Date:  2005-10       Impact factor: 5.078

2.  Rapid HIV test distribution--United States, 2003-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-23       Impact factor: 17.586

3.  Promoting HIV risk awareness and testing in Latinos living on the U.S.-Mexico border: the Tú No Me Conoces social marketing campaign.

Authors:  Alisa M Olshefsky; Michelle M Zive; Rosana Scolari; María Zuñiga
Journal:  AIDS Educ Prev       Date:  2007-10

Review 4.  Mass media interventions for promoting HIV testing: Cochrane systematic review.

Authors:  J Vidanapathirana; M J Abramson; A Forbes; C Fairley
Journal:  Int J Epidemiol       Date:  2006-02-07       Impact factor: 7.196

5.  Effectiveness of a mass media campaign in promoting HIV testing information seeking among African American women.

Authors:  Kevin C Davis; Jennifer Uhrig; Douglas Rupert; Jami Fraze; Joshua Goetz; Michael Slater
Journal:  J Health Commun       Date:  2011-06-27

6.  HIV counseling and testing among Hispanics at CDC-funded sites in the United States, 2007.

Authors:  Denise Duran; Hussain R Usman; John Beltrami; Maria E Alvarez; Linda Valleroy; Cynthia M Lyles
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

7.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

8.  Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing.

Authors:  Sandra Schwarcz; T Anne Richards; Heidi Frank; Conrad Wenzel; Ling Chin Hsu; Chi-Sheng Jennie Chin; Jessie Murphy; James Dilley
Journal:  AIDS Care       Date:  2011-07

9.  Current HIV epidemiology and revised recommendations for HIV testing in health-care settings.

Authors:  Bernard Branson
Journal:  J Med Virol       Date:  2007       Impact factor: 2.327

10.  HIV testing rates and testing locations, by race and ethnicity.

Authors:  Michele A Rountree; Lynn Chen; Adama Brown; Elizabeth C Pomeroy
Journal:  Health Soc Work       Date:  2009-11
View more
  5 in total

1.  Primary health care: a necessary, current and profitable investment.

Authors:  Sandra Girón
Journal:  Colomb Med (Cali)       Date:  2015-09-30

2.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

3.  An evaluation of the SD Bioline HIV/syphilis duo test.

Authors:  Jeffrey Holden; Joshua Goheen; Mary Jett-Goheen; Mathilda Barnes; Yu-Hsiang Hsieh; Charlotte A Gaydos
Journal:  Int J STD AIDS       Date:  2017-06-29       Impact factor: 1.359

4.  Effectiveness of HIV Stigma Interventions for Men who have Sex with Men (MSM) With and Without HIV in the United States: A Systematic Review and Meta-Analyses.

Authors:  Jayleen K L Gunn; Cherie Rooks-Peck; Megan E Wichser; Christa Denard; Donna Hubbard McCree; William L Jeffries; Julia B DeLuca; Leslie W Ross; Adrienne Herron; Terrika Barham; Stephen A Flores; Darrel H Higa
Journal:  AIDS Behav       Date:  2021-07-14

5.  HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam.

Authors:  M Bartelsman; I K Joore; J E van Bergen; A A Hogewoning; F R Zuure; M G van Veen
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.